Alexion Pharmaceuticals (ALXN) Q4 Earnings and Revenues Surpass EstimatesZacks Investment Research • 02/04/21
Amgen, Biogen, Gilead, Merck, Pfizer, and More Health Care Earnings Coming This Week24/7 Wall Street • 01/31/21
Alexion Pharmaceuticals (ALXN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 01/28/21
Alexion to Report Fourth Quarter and Full Year 2020 Results on Thursday, February 4, 2021Business Wire • 01/25/21
Will Alexion (ALXN) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 01/21/21
INVESTIGATION ALERT: Halper Sadeh LLP Investigates ALXN, CHNG, RP, RNET, MDCA, NK; Shareholders Are Encouraged to Contact the FirmPRNewsWire • 01/14/21
Alexion (ALXN) to Pause Enrollment in COVID-19 Study on UltomirisZacks Investment Research • 01/14/21
Alexion Highlights Commercial, Clinical and Financial Progress at the 39th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/12/21
ALERT: Halper Sadeh LLP Investigates ALXN, SPWH, CBMG, STND, EIDX; Shareholders Are Encouraged to Contact the FirmPRNewsWire • 01/05/21
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers - ALXN, TCF, CATM, TCPPRNewsWire • 12/24/20
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Alexion Pharmaceuticals, Inc. - ALXNPRNewsWire • 12/19/20
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - ALXN, CATM, TCP, PRVLPRNewsWire • 12/16/20